Ocular manifestations of the antiphospholipid syndrome

Ocular manifestations of the antiphospholipid syndrome
复制标题

抗磷脂综合征的眼部表现

DOI:
--
复制
发表时间:
2010
影响因子:
4.1
通讯作者:
Johnny Tang
Johnny Tang
中科院分区:
医学2区
文献类型:
--
作者:
V. Utz;Johnny Tang

文献摘要

参考文献

被引文献

相似文献

抗磷脂综合征(APS)是一种自身免疫性疾病,其特征是针对带负电荷磷脂的一组异质性抗体,包括抗磷脂抗体(aPL)、抗心磷脂抗体(aCL)和β-2糖蛋白I(aβ-2-GP 1)。这种疾病的主要特征包括动脉和静脉血栓形成和反复流产。眼睛的血管系统经常被累及,并且可能是表现。在没有传统血栓栓塞危险因素的年轻眼血管闭塞性疾病患者中,应考虑APS的诊断。这些患者的管理涉及与血液科医生/肿瘤科医生或血液流变学专家的团队方法,以管理这些患者的凝血状态,以防止进一步的全身血管闭塞。
Antiphospholipid syndrome (APS) is an autoimmune disease characterised by a heterogenous group of antibodies directed against negatively charged phospholipids including antiphospholipid antibodies (aPL), anticardiolipin antibodies (aCL) and β-2 glycoprotein I (aβ-2-GP1). The major features of this disorder include arterial and venous thrombosis and recurrent fetal loss. The vasculature of the eye is frequently involved and may be the presenting manifestation. A diagnosis of APS should be considered in a young patients without traditional thromboembolic risk factors presenting with ocular vaso-occlusive disease. Management of these patients involves a team-approach with a haematologist/oncologist or rheumatologist to manage the coagulation status of these patients to prevent further systemic vascular occlusions.
白血病中与抗心磷脂抗体相关的同时双侧视网膜中央静脉阻塞。
DOI: 10.1016/s0002-9394(01)00911-4
发表时间: 2001
影响因子: 4.2
作者:
Al-Abdulla,NA;Thompson,JT;LaBorwit,SE
通讯作者: LaBorwit,SE
一名六岁女性患者的抗磷脂抗体综合征。
DOI: 10.1016/s0002-9394(02)02078-0
发表时间: 2003
影响因子: 4.2
作者:
Hartnett,MElizabeth;Laposata,Michael;VanCott,Elizabeth
通讯作者: VanCott,Elizabeth
与抗磷脂抗体相关的血管闭塞性视网膜病(狼疮抗凝性视网膜病)。
DOI: 10.1016/s0161-6420(89)32825-9
发表时间: 1989
期刊: Ophthalmology
影响因子: 13.7
作者:
Kleiner,RC;Najarian,LV;Schatten,S;Jabs,DA;Patz,A;Kaplan,HJ
通讯作者: Kaplan,HJ